Close Menu

UCSF

A pair of studies has established a potential role for specific gut bacteria in the progression of MS, suggesting therapeutic targeting of the microbiota as a potential treatment.

In PNAS this week: links between the gut microbiome and multiple sclerosis, and more.

The researchers used this approach to show how non-coding variation associated with human immune dysfunction alters context-specific gene programs. 

The consortium aims to advance the use of genomics in the clinic, with a particular  focus on diverse and underserved patient populations.

The $10 million donation from Mark Zuckerberg and Priscilla Chan should accelerate data sharing and alleviate shortage in bioinformatics expertise.

The gift will support work being done by Atul Butte using publicly availably health data to gain new insights on disease.

The firm recently released two droplet digital PCR-based assays that can characterize edits generated by CRISPR-Cas9 or other genome editing tools.

Focusing on drugs that appeared to reverse cancer-related gene expression signatures, researchers identified candidate compounds that thwarted cancer cell lines.

This finding has the potential to expand the current utility of the panel to identify an important subgroup of people who would benefit from less treatment, the firm said. 

The UCSF Helen Diller Family Comprehensive Cancer Center has installed GenomOncology's GO Clinical Workbench to support the institution's UCSF500 NGS panel.

Pages

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.